Transgenic zebrafish eggs containing bactericidal peptide is a novel food supplement enhancing resistance to pathogenic infection of fish

Fish and Shellfish Immunology

Volumn 28, Issue 3, 2010, Pages 419-427

  Lin, Cheng Yung ^a   Yang, Ping Hsi ^a   Kao, Chia Ling ^a   Huang, Han I ^a   Tsai, Huai Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bactericide; Embryos; Feeding; Lactoferrincin; Transgenic; Zebrafish

Indexed keywords

AEROMONAS HYDROPHILA; BOVINAE; DANIO RERIO; EDWARDSIELLA TARDA; ESCHERICHIA COLI;

EID: 76749155815     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2009.11.019     Document Type: Article

References (50)

1. Groves M.L. The isolation of a red protein from milk. J Am Chem Soc 82 (1960) 3345-3350
2. Baveye S., Elass E., Mazurier J., Spik G., and Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37 (1999) 281-286
3. Chierici R. Antimicrobial actions of lactoferrin. Adv Nutr Res 10 (2001) 247-269
4. Baker E.N., and Baker H.M. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 91 (2009) 3-10
5. Tomita M., Wakabayashi H., Shin K., Yamauchi K., Yaeshima T., and Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 91 (2009) 52-57
6. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., and Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121 (1992) 130-136
7. Yamauchi K., Tomita M., Giehl T.J., and Ellison R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61 (1993) 719-728
8. Bellamy W., Takase M., Wakabayashi H., Kawase K., and Tomita M. Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73 (1992) 472-479
9. Bellamy W., Wakabayashi H., Takase M., Kawase K., Shimamura S., and Tomita M. Killing of Candida albicans by lactoferricin-B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol 182 (1993) 97-105
10. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., and Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37 (1998) 4288-4298
11. Vorland L.H., Ulvatne H., Rekdal O., and Svendsen J.S. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 31 (1999) 467-473
12. Farnaud S., Spiller C., Moriarty L.C., Patel A., Gant V., Odell E.W., et al. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol Lett 233 (2004) 193-199
13. Omata Y., Satake M., Maeda R., Saito A., Shimazaki K., Yamauchi K., et al. Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedae sporozoites by treatment with bovine lactoferricin. J Vet Med Sci 63 (2001) 187-190
14. Turchany J.M., Aley S.B., and Gillin F.D. Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun 63 (1995) 4550-4552
15. Tanaka T., Omata Y., Saito A., Shimazaki K., Yamauchi K., Takase M., et al. Toxoplasma gondii: parasiticidal effects of bovine lactoferricin against parasites. Exp Parasitol 81 (1995) 614-617
16. Bellamy W., Yamauchi K., Wakabayashi H., Takase M., Takakura N., Shimamura S., et al. Antifungal properties of lactoferricin-B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett Appl Microbiol 18 (1994) 230-233
17. Munoz A., and Marcos J.F. Activity and mode of action against fungal phytopathogens of bovine lactoferricin-derived peptides. J Appl Microbiol 101 (2006) 1199-1207
18. Di Biase A.M., Pietrantoni A., Tinari A., Siciliano R., Valenti P., Antonini G., et al. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J Med Virol 69 (2003) 495-502
19. Jenssen H., Andersen J.H., Uhlin-Hansen L., Gutteberg T.J., and Rekdal O. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antivir Res 61 (2004) 101-109
20. Jenssen H. Anti herpes simplex virus activity of lactoferrin/lactoferricin - an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci 62 (2005) 3002-3013
21. Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., and Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antivir Res 69 (2006) 98-106
22. Jenssen H., Sandvik K., Andersen J.H., Hancock R.E.W., and Gutteberg T.J. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin. Antivir Res 79 (2008) 192-198
23. Rocha A., Ruiz S., Estepa A., and Joll J.M. Application of inducible and targeted gene strategies to produce transgenic fish: a review. Mar Biotechnol 6 (2004) 118-127
24. Hwang G.L., Muller F., Rahman M.A., Williams D.W., Murdock P.J., Pasi K.J., et al. Fish as bioreactors: transgene expression of human coagulation factor VII in fish embryos. Mar Biotechnol 6 (2004) 485-492
25. Morita T., Yoshizaki G., Kobayashi M., Watabe S., and Takeuchi T. Fish eggs as bioreactors: the production of bioactive luteinizing hormone in transgenic trout embryos. Transgenic Res 13 (2004) 551-557
26. Lin S.B., Fan T.W., Wu J.L., Hui C.F., and Chen J.Y. Immune response and inhibition of bacterial growth by electrotransfer of plasmid DNA containing the antimicrobial peptide, epinecidin-1, into zebrafish muscle. Fish Shellfish Immunol 26 (2009) 451-458
27. Lin C.Y., Yung R.F., Lee H.C., Chen W.T., Chen Y.H., and Tsai H.J. Myogenic regulatory factors Myf5 and Myod function distinctly during craniofacial myogenesis of zebrafish. Dev Biol 299 (2006) 594-608
28. Hsiao C.D., Hsieh F.J., and Tsai H.J. Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish. Dev Dyn 220 (2001) 323-336
29. Lee H.C., Tsai J.N., Liao P.Y., Tsai W.Y., Lin K.Y., Chuang C.C., et al. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo. BMC Dev Biol 7 (2007) 93-104
30. Atkins T.W. Biodegradation of poly (ethylene adipate) microcapsules in physiological media. Biomaterials 19 (1998) 61-67
31. Li S.S., and Tsai H.J. Transgenic microalgae as a non-antibiotic bactericide producer to defend against bacterial pathogen infection in the fish digestive tract. Fish Shellfish Immunol 26 (2009) 316-325
32. Warga R.M., and Nusslein-Volhard C. Origin and development of the zebrafish endoderm. Development 126 (1999) 827-838
33. Pressley M.E., Phelan P.E., Witten P.E., Mellon M.T., and Kim C.H. Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebrafish. Dev Comp Immunol 29 (2005) 501-513
34. Kim H.K., Chun D.S., Kim J.S., Yun C.H., Lee J.H., Hong S.K., et al. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Appl Microbiol Biotechnol 72 (2006) 330-338
35. Feng X., Wang J., Shan A., Teng D., Yang Y., Yao Y., et al. Fusion expression of bovine lactoferricin in Escherichia coli. Protein Expr Purif 47 (2006) 110-117
36. Wang H.K., Zhao X.H., and Lu F.P. Heterologous expression of bovine lactoferricin in Pichia methanolica. Biochemistry (Mosc) 72 (2007) 640-643
37. Samuelsen O., Haukland H.H., Kahl B.C., von Eiff C., Proctor R.A., Ulvatne H., et al. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother 56 (2005) 1126-1129
38. Sullivan C., and Kim C.H. Zebrafish as a model for infectious disease and immune function. Fish Shellfish Immunol 25 (2008) 341-350
39. Rahman M.A., Mak R., Ayad H., Smith A., and Maclean N. Expression of a novel piscine growth hormone gene results in growth enhancement in transgenic tilapia (Oreochromis niloticus). Transgenic Res 7 (1998) 357-369
40. Martinez R., Juncal J., Zaldivar C., Arenal A., Guillen I., Morera V., et al. Growth efficiency in transgenic tilapia (Oreochromis sp.) carrying a single copy of an homologous cDNA growth hormone. Biochem Biophys Res Commun 267 (2000) 466-472
41. Cook J.T., McNiven M.A., Richardson G.F., and Sutterlin A.M. Growth rate, body composition and feed digestibility/conversion of growth-enhanced transgenic Atlantic salmon (Salmo salar). Aquaculture 188 (2000) 15-32
42. Nam Y.K., Noh J.K., Cho Y.S., Cho H.J., Cho K.N., Kim C.G., et al. Dramatically accelerated growth and extraordinary gigantism of transgenic mud loach Misgurnus mizolepis. Transgenic Res 10 (2001) 353-362
43. Caelers A., Maclean N., Hwang G.L., Eppler E., and Reinecke M. Expression of endogenous and exogenous growth hormone (GH) messenger (m) RNA in a GH-transgenic tilapia (Oreochromis niloticus). Transgenic Res 14 (2005) 95-104
44. Jia X., Patrzykat A., Devlin R.H., Ackerman P.A., Iwama G.K., and Hancock R.E.W. Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections. Appl Environ Microbiol 66 (2000) 1928-1932
45. Dunham R.A., Warr G.W., Nichols A., Duncan P.L., Argue B., Middleton D., et al. Enhanced bacterial disease resistance of transgenic channel catfish Ictalurus punctatus possessing cecropin genes. Mar Biotechnol 4 (2002) 338-344
46. Yazawa R., Hirono I., and Aoki T. Transgenic zebrafish expressing chicken lysozyme show resistance against bacterial diseases. Transgenic Res 15 (2006) 385-391
47. Wang R., Zhang P., Gong Z., and Hew C.L. Expression of the antifreeze protein gene in transgenic goldfish (Carassius auratus) and its implication in cold adaptation. Mol Mar Biol Biotechnol 4 (1995) 20-26
48. Winn R.N., Norris M.B., Brayer K.J., Torres C., and Muller S.L. Detection of mutations in transgenic fish carrying a bacteriophage lambda cll transgene target. Proc Natl Acad Sci U S A 97 (2000) 12655-12660
49. Winn R.N., Norris M., Muller S., Torres C., and Brayer K. Bacteriophage lambda and plasmid pUR288 transgenic fish models for detecting in vivo mutations. Mar Biotechnol 3 (2001) S185-S195
50. Sarmasik A., Warr G., and Chen T.T. Production of transgenic medaka with increased resistance to bacterial pathogens. Mar Biotechnol 4 (2002) 310-322